Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

Clinical Trial ID NCT00002723

PubWeight™ 8.90‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00002723

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. J Clin Oncol 2003 6.93
2 Pain predicts overall survival in men with metastatic castration-refractory prostate cancer. J Clin Oncol 2008 2.31
Next 100